Indoco Remedies Latest News

  1. USFDA has concluded inspection at company’s Clinical Research Organisation, AnaCipher with zero 483s
    Date:18-10-2019
  2. The inspection ended with 2 observations
    Date:16-10-2019
  3. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed about the scheduled Con Call meeting planned for 30th October, 2019. 

    Date:14-10-2019
  4. This is the first ANDA approval for the company after receipt of warning letter in March 2017 for Goa plant II and III
    Date:07-10-2019
  5. This is the first ANDA approval for the company after receipt of warning letter in March 2017 for Goa plant II and III
    Date:07-10-2019
  6. The inspection was held from September 16, 2019 to September 20, 2019 and resulted in 2 observations
    Date:23-09-2019
  7. Indoco has now received a full GMP status for its Goa Plant I
    Date:13-09-2019
  8. Indoco Remedies has informed about submission of Annual Report 2018-19 of the company. 

    The above information is a part of company’s filings submitted to BSE....

    Date:01-08-2019
  9. The inspection was held from May 27, 2019 to June 4, 2019 and the company had received 4 observations
    Date:26-07-2019
  10. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed about Press Release. 

    The above information is a part of company’s filings submitted t...

    Date:15-07-2019
Return to Top
Puchho Befikar